Status: Recruiting
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
This is a single-arm pilot study of the feasibility and safety of metformin in patients with clonal cytopenia of undetermined significance (CCUS) or lower-risk myelodysplastic neoplasms (LR-MDS).
Participants needed: 40
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Kirsten GrønbækUpdated: Nov 22, 2024Locations: 1
Eligibility criteria
LR-MDS according to the revised international prognostic scoring system (IPSS-R)... [+6]
Any prior treatment with metformin [+15]